Chapter

Cardiac oncology

Maurizio Galderisi, Juan Carlos Plana, Thor Edvardsen, Vitantonio Di Bello and Patrizio Lancellotti

in The EACVI Textbook of Echocardiography

Second edition

Published on behalf of © European Society of Cardiology

Published in print November 2016 | ISBN: 9780198726012
Published online December 2016 | e-ISBN: 9780191792991 | DOI: http://dx.doi.org/10.1093/med/9780198726012.003.0064

Series: The European Society of Cardiology Textbooks

Cardiac oncology

More Like This

Show all results sharing these subjects:

  • Cardiovascular Medicine
  • Radiography

GO

Show Summary Details

Preview

Cancer therapeutics may induce cardiac damage in the left and the right ventricle. Radiotherapy most frequently induces valvular damage, carotid stenosis, and coronary artery disease. Pericardial disease may be due to both chemo- and radiotherapy. The manifestations of both chemo- and radiotherapy can develop acutely but also become overt years after their performance, in particular after radiotherapy. The main cardiac damage of cancer therapeutics-related cardiac dysfunction (CTRCD) corresponds to the reduction of left ventricular (LV) systolic function. The Expert Consensus document from ASE and EACVI has defined CTRCD as a decrease in LV ejection fraction (LVEF) of greater than 10 percentage points, to a value less than 53%. The accurate calculation of LVEF at baseline and during follow-up is extremely important. The assessment of LV longitudinal function, in particular of speckle tracking-derived global longitudinal strain (GLS), can provide additional information, allowing early, subclinical detection of CTRCD. The ideal strategy could be to compare the measurements of GLS obtained during chemotherapy, with the one obtained at baseline. An integrated approach with the use of echocardiography at standardized, clinical preselected intervals with biomarker (ultrasensitive troponin) assessment prior to each chemotherapy cycle could be suggested in patients at high risk of CTRCD. Follow-up after therapy should depend on the type of chemotherapy/radiotherapy and the presence/absence of on-therapy CTRCD. Long-term follow-up should be planned after radiotherapy.

Chapter.  4916 words.  Illustrated.

Subjects: Cardiovascular Medicine ; Radiography

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.